Cargando…
Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells
Hepatitis B virus (HBV) infection is a leading cause of hepatocellular carcinoma (HCC), one of the most prevalent malignant tumors worldwide that poses a significant threat to human health. The multifunctional regulator known as Hepatitis B virus X-protein (HBx) interacts with host factors, modulati...
Autores principales: | Han, Ning, Zhang, Qingbo, Tang, Xiaoqiong, Bai, Lang, Yan, Libo, Tang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221477/ https://www.ncbi.nlm.nih.gov/pubmed/37243268 http://dx.doi.org/10.3390/v15051182 |
Ejemplares similares
-
Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases
por: Fruergaard, Marlene Uglebjerg, et al.
Publicado: (2023) -
Identification of p90 Ribosomal S6 Kinase 2 as a Novel Host Protein in HBx Augmenting HBV Replication by iTRAQ‐Based Quantitative Comparative Proteomics
por: Yan, Li‐Bo, et al.
Publicado: (2018) -
Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases
por: Andersen, Jacob Lauwring, et al.
Publicado: (2018) -
Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2
por: Malakhova, Margarita, et al.
Publicado: (2009) -
The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility
por: Artamonov, Mykhaylo, et al.
Publicado: (2013)